Cargando…
A Combined RNA Signature Predicts Recurrence Risk of Stage I-IIIA Lung Squamous Cell Carcinoma
OBJECTIVE: Recurrence remains the main cause of the poor prognosis in stage I-IIIA lung squamous cell carcinoma (LUSC) after surgical resection. In the present study, we aimed to identify the long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) related to the recurrence of...
Autores principales: | Sun, Li, Li, Juan, Li, Xiaomeng, Yang, Xuemei, Zhang, Shujun, Wang, Xue, Wang, Nan, Xu, Kanghong, Jiang, Xinquan, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236863/ https://www.ncbi.nlm.nih.gov/pubmed/34194476 http://dx.doi.org/10.3389/fgene.2021.676464 |
Ejemplares similares
-
A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma
por: Li, Xiaomeng, et al.
Publicado: (2021) -
A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer
por: Xin, Cheng, et al.
Publicado: (2023) -
The Safety and Efficacy of Preoperative Immunotherapy Combined with Chemotherapy in Patients with Stage IIIA-IIIB Lung Squamous Cell Carcinoma
por: Wang, Ying, et al.
Publicado: (2022) -
Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma
por: Huang, Qiang, et al.
Publicado: (2022) -
Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC
por: Zhang, Haoran, et al.
Publicado: (2023)